Estudio de sensibilidad antifúngica para posaconazol y caspofungina en levaduras responsables de infección fúngica invasiva (2002-2003). Evaluación del sistema E-test

Fridkin, 1996, Epidemiology of nosocomial fungal infections, Clin Microbiol Rev, 9, 499, 10.1128/CMR.9.4.499 Cuenca-Estrella, 2006, Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi, Antimicrob Agents Chemother, 50, 917, 10.1128/AAC.50.3.917-921.2006 Espinel-Ingroff, 2003, In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature, Rev Iberoam Micol, 20, 121 Sims, 2006, Correlation between microdilution, E-test, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp, J Clin Microbiol, 44, 2105, 10.1128/JCM.02591-05 Clinical and Laboratory Standards Institute (CLSI) reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard. Document M27-A2. Velasco, 2005, ICAAC 2005, 442 Pfaller, 2006, In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance, J Clin Microbiol, 44, 760, 10.1128/JCM.44.3.760-763.2006 Magill, 2006, Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy, J Clin Microbiol, 44, 529, 10.1128/JCM.44.2.529-535.2006 Espinel-Ingroff, 2006, J Clin Microbiol, 44, 3616, 10.1128/JCM.01187-06 Chryssanthou, 2002, J Clin Microbiol, 40, 3841, 10.1128/JCM.40.10.3841-3844.2002